beta-catenin (S33A, S37A, T41A, S45A)-pcw107-V5 Citations (1)

Originally described in: Systematic identification of signaling pathways with potential to confer anticancer drug resistance.
Martz CA, Ottina KA, Singleton KR, Jasper JS, Wardell SE, Peraza-Penton A, Anderson GR, Winter PS, Wang T, Alley HM, Kwong LN, Cooper ZA, Tetzlaff M, Chen PL, Rathmell JC, Flaherty KT, Wargo JA, McDonnell DP, Sabatini DM, Wood KC Sci Signal. 2014 Dec 23;7(357):ra121. doi: 10.1126/scisignal.aaa1877. PubMed Journal

---

Articles Citing beta-catenin (S33A, S37A, T41A, S45A)-pcw107-V5

Articles
Semaphorin Receptors Antagonize Wnt Signaling Through Beta-Catenin Degradation. Hoard TM, Liu K, Cadigan KM, Giger RJ, Allen BL. bioRxiv [Preprint]. 2024 May 29:2024.05.29.596372. doi: 10.1101/2024.05.29.596372. PubMed

If you have published an article using this material, please email us at to have your article added to this page.